| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |